Anlotinib Plus Platinum-etoposide in First-line Treatment of Extensive-stage Small-cell Lung Cancer: a Single-arm Phase II Trial
Latest Information Update: 06 Dec 2022
At a glance
- Drugs Carboplatin (Primary) ; Catequentinib (Primary) ; Cisplatin (Primary) ; Etoposide (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 31 Jan 2021 Results of an interim analysis presented at the 2020 World Conference on Lung Cancer
- 28 Dec 2020 New trial record